Ashley Capoot

OpenAI launches new GPT-5 model for all ChatGPT users OpenAI announced GPT-5, its latest and most advanced AI model.

New: GPT-5 is here! And OpenAI is making it available to everyone, including its free users.

The company said the AI model is smarter, faster and "a lot more useful," particularly across domains like writing, coding and health care.

Details here:
www.cnbc.com/2025/08/07/o...

Former X CEO Linda Yaccarino takes helm at digital health company eMed Yaccarino stepped down as CEO of Elon Musk's social media platform X in July.

New: Linda Yaccarino, the former chief executive of Elon Musk’s social media platform X, is pivoting into health care.

She's been named CEO of eMed, which is part of the growing group of companies trying to capitalize on the sky-high demand for GLP-1s.

www.cnbc.com/2025/08/05/f...

Scale AI cuts 14% of workforce after Meta investment, hiring of founder Wang Scale AI said it's cutting 14% of its staff weeks after Meta invested $14.3 billion in the startup and hired a number of top staffers.

New: Scale AI cuts 14% of workforce after Meta investment, hiring of founder Wang

www.cnbc.com/2025/07/16/s...

Meta CEO Zuckerberg says first AI data supercluster will come online in 2026 Mark Zuckerberg on Monday said he plans to invest "hundreds of billions of dollars" into artificial intelligence infrastructure.

A supercluster is a large, complex computing network that’s designed to train advanced AI models and handle their workloads. Zuckerberg said Meta’s first supercluster is called Prometheus, and that the company is building several other multi-gigawatt clusters.

The twists keep coming! AI startup Cognition announced it’s acquiring Windsurf, the AI coding company that lost its CEO and several other senior employees to Google just days earlier.

www.cnbc.com/2025/07/14/c...

Linda Yaccarino steps down as CEO of Elon Musk's X Yaccarino's departure comes one day after Musk's artificial intelligence chatbot Grok repeatedly made antisemitic comments.

New: Linda Yaccarino steps down as CEO of Elon Musk’s X www.cnbc.com/2025/07/09/l...

Ilya Sutskever becomes CEO of Safe Superintelligence after Meta poached Daniel Gross Ilya Sutskever will assume the CEO role at Safe Superintelligence, the AI startup he co-founded after leaving OpenAI.

New: OpenAI co-founder Ilya Sutskever said he will assume the CEO role at Safe Superintelligence. The announcement comes after Meta poached Daniel Gross, a longtime entrepreneur and AI investor who had been acting as the chief executive.

www.cnbc.com/2025/07/03/i...

Amazon reorganizes health-care business in latest bid to crack multitrillion-dollar market Amazon is reorganizing its health-care business into six "pillars" to simplify its structure in a market where it's spent billions of dollars on acquisitions.

Scoop: Amazon is reorganizing its health business into six "pillars" after a series of executive departures at the company.

It has tapped a slate of longtime Amazon leaders and One Medical executives to oversee the divisions.

w/ @anniepalmer.bsky.social!
www.cnbc.com/2025/06/13/a...

Zuckerberg makes his biggest AI bet as Meta nears $14 billion stake in Scale AI, hires founder Wang Meta's Mark Zuckerberg is bringing in Scale AI CEO Alexandr Wang to help the social media company better execute on its AI ambitions.

In Scale AI's Alexandr Wang, Zuckerberg may have found Meta's wartime AI leader www.cnbc.com/2025/06/10/z...

by @jonathanvanian.bsky.social and @ashleycapoot.cnbc.com

OpenAI hits $10 billion in annual recurring revenue fueled by ChatGPT growth OpenAI is now generating $10 billion in annual recurring revenue, according to a company spokesperson

Exclusive w/ Kate Rooney: OpenAI has hit $10 billion in annual recurring revenue less than three years after launching its popular ChatGPT chatbot.

www.cnbc.com/2025/06/09/o...

Omada Health prices IPO at $19 per share, in middle of expected range Omada Health is set to start trading on the Nasdaq, hitting the market a few weeks after Hinge Health, another emerging company in the space.

New: Omada Health priced its IPO at $19 per share on Thursday, in the middle of the expected range.

The virtual chronic care company said in a press release that 7.9 million shares are being sold in the offering, amounting to $150 million.

www.cnbc.com/2025/06/05/o...

Reddit sues AI startup Anthropic for breach of contract, 'unfair competition' Reddit's lawsuit against Anthropic is the latest generative AI battle to find its way to the courtroom.

Reddit sues AI startup Anthropic for breach of contract, 'unfair competition' - with @ashleycapoot.cnbc.com
www.cnbc.com/2025/06/04/r...

Omada Health aims to go public with market cap of up to $1.1 billion Omada Health updated its IPO prospectus on Thursday, indicating that it plans to raise up to $158 million in its offering.

Omada Health: Hey Hinge, hold my beer...

Diabetes management firm aims to go public with market cap of up to $1.1 billion via @ashleycapoot.cnbc.com

Some news! In addition to my health tech reporting, I’m helping out with AI coverage for @cnbc.com. I'll be writing about the major companies in the space, including OpenAI, Anthropic, etc.

I'm so excited to dig in! Get in touch at ashley.capoot@nbcuni.com or on Signal at ashleycapoot.22 🥳🤠 👩‍💻

Ambience announces OpenAI-powered medical coding model that outperforms physicians Ambience is part of the red-hot market that uses AI to draft clinical notes in real time as doctors consensually record their visits with patients

Exclusive: Ambience Healthcare on Tuesday announced a new ICD-10 coding model that outperforms doctors by 27%. The company used tools from OpenAI to build the new model.

Details here!
www.cnbc.com/2025/05/27/o...

Sam Altman's $6.4 billion bet on Jony Ive has Zuckerberg-like qualities OpenAI is making a big bet in purchasing Jony Ive's nascent startup, but it's a deal reminiscent of some made by Mark Zuckerberg.

New: Sam Altman’s $6.4 billion bet on Jony Ive is a callback to strategy employed by another Silicon Valley tech billionaire: Meta CEO Mark Zuckerberg.

www.cnbc.com/2025/05/22/s...

Hinge Health aims to raise up to $437 million in IPO, pricing at $28 to $32 per share Hinge Health said in a filing on Tuesday that it plans to raise more than $437 million in its upcoming initial public offering.

New: We have pricing! Hinge Health is planning to raise up to $437 million in its upcoming IPO.

The company selling about 13.7 million shares in the offering, at an expected pricing range of $28 to $32 per share.

More here:
www.cnbc.com/2025/05/13/h...

Virtual chronic care company Omada Health files for IPO Omada Health filed for an IPO on Friday, the latest digital health company to announce its intent to test the public market.

New: Omada Health has officially filed for an IPO!

The company offers virtual care programs for patients w/ chronic conditions like prediabetes, diabetes and hypertension. It generated $169.8 million in revenue during 2024, up 38% from a year earlier.

www.cnbc.com/2025/05/09/v...

Virtual chronic care company Omada Health files for IPO Omada Health filed for an IPO on Friday, the latest digital health company to announce its intent to test the public market.

New: Omada Health has officially filed for an IPO!

The company offers virtual care programs for patients w/ chronic conditions like prediabetes, diabetes and hypertension. It generated $169.8 million in revenue during 2024, up 38% from a year earlier.

www.cnbc.com/2025/05/09/v...

From 'Cockroach Award' to the Big Board: Hinge Health's unlikely path to IPO Hinge Health, a 10-year-old digital health company, is poised to kick off its IPO roadshow at a time when fellow upstarts are delaying plans to go public.

In the barren desert that is the IPO market, Hinge Health looks set to soon take the plunge. Here's a profile by @ashleycapoot.cnbc.com on the company's CEO www.cnbc.com/2025/05/05/f...

From 'Cockroach Award' to the Big Board: Hinge Health's unlikely path to IPO Hinge Health, a 10-year-old digital health company, is poised to kick off its IPO roadshow at a time when fellow upstarts are delaying plans to go public.

“La Cucaracha” is a folk song about a cockroach that gets its leg knocked off but still manages to dance around the kitchen.
Roaches are notoriously resilient.
Even in this volatile market, Hinge Health’s Cuban CEO is taking that approach to the company’s IPO, reports @ashleycapoot.cnbc.com.

Function Health buys Ezra, launches full-body scan for a third of the price Function Health on Monday announced it has acquired the full-body MRI scanning company Ezra

New: Blood testing startup Function Health on Monday announced the acquisition of full-body MRI scanning company Ezra and launched a new, 22-minute scan for $499.

www.cnbc.com/2025/05/05/f...

From 'Cockroach Award' to the Big Board: Hinge Health's unlikely path to IPO Hinge Health, a 10-year-old digital health company, is poised to kick off its IPO roadshow at a time when fellow upstarts are delaying plans to go public.

New: Daniel Perez, the 39-year-old co-founder and CEO of Hinge Health, is preparing to steer the company through an IPO in a time of extreme economic uncertainty.

Here's a look at his life, leadership and how he managed the "one in a million chance" of getting there.

www.cnbc.com/2025/05/05/f...

Oracle engineers caused days-long software outage at U.S. hospitals Oracle engineers triggered a five-day outage at several Community Health Systems hospitals, causing the facilities to temporarily return to paper-based records.

New: Oracle engineers mistakenly triggered a 5-day software outage at a number of Community Health Systems hospitals, causing them to activate downtime procedures.

The engineers deleted critical storage connected to a key database on accident, a CHS spokesperson said.

www.cnbc.com/2025/04/28/o...

Brain implant cleared by FDA for Precision Neuroscience, a Musk Neuralink rival Precision Neuroscience announced that a core component of its brain implant system has been approved by the FDA.

New: Neurotech startup Precision Neuroscience announced that a core component of its brain implant system has been approved by the FDA.

The clearance is a major milestone for the four-year-old company, but it still has more work to do.

Details here! 🧠
www.cnbc.com/2025/04/17/b...

23andMe bankruptcy under congressional investigation for customer data The House Committee on Energy and Commerce is investigating 23andMe's decision to file for bankruptcy

Exclusive: The House Committee on Energy and Commerce is investigating 23andMe's decision to file for bankruptcy and has expressed concern that its sensitive genetic data is "at risk of being compromised.”

More details here: www.cnbc.com/2025/04/17/2...

UnitedHealth is making struggling doctors repay loans issued after last year's cyberattack UnitedHealth is aggressively recouping the loans the company offered doctors following the 2024 cyberattack at its Change Healthcare unit.

New: UnitedHealth Group has begun clawing back the loans it gave out to providers affected by the Change Healthcare cyberattack last year.

Some practices are being asked to "immediately repay" hundreds of thousands of dollars in a matter of days.

Details here:
www.cnbc.com/2025/04/11/u...

Digital health startup Transcarent takes Accolade private in $621 million deal Transcarent CEO Glen Tullman previously led Livongo, which was purchased by Teladoc in a 2020 agreement that valued the company at $18.5 billion.

New: Transcarent on Tuesday announced it has completed its $621 million acquisition of Accolade.

Accolade is the latest digital health company to exit the public markets as the sector has struggled to readjust to a more muted growth environment.

Details here!
www.cnbc.com/2025/04/08/d...

Trump's tariff rates for other countries radically larger than World Trade data A report suggests the trade-weighted average tariff rates in most countries are much different than the figures touted by the Trump administration.

one r two ffs one r two ffs one r two ffs
www.cnbc.com/2025/04/04/t...

23andMe co-founder lashes out at CEO Wojcicki after bankruptcy filing, says board lacked oversight 23andMe co-founder Linda Avey expressed frustration about the fall of the genetic testing company in a social media post.

ICYMI: 23andMe co-founder Linda Avey took to social media with harsh criticism of CEO Anne Wojcicki after the company’s bankruptcy filing this week.

www.cnbc.com/2025/03/26/2...